Bogart Wealth LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bogart Wealth LLC’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7K	Buy	16 +9	+129%	+$2.55K	﹤0.01%	1219
2026 Q1	$1.95K	Buy	+7	New	+$2.02K	﹤0.01%	1281
2023 Q3	–	Sell	-14	Closed	-$5.31K	–	1074
2023 Q2	$5.31K	Hold	14	–	–	﹤0.01%	695
2023 Q1	$6.71K	Hold	14	–	–	﹤0.01%	660
2022 Q4	$5.9K	Hold	14	–	–	﹤0.01%	635
2022 Q3	$6K	Hold	14	–	–	﹤0.01%	648
2022 Q2	$7K	Buy	14 +1	+8%	+$521	﹤0.01%	584
2022 Q1	$7K	Buy	+13	New	+$7.84K	﹤0.01%	529

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bogart Wealth LLC's BIO Position: Q2 2026 in Review

Bogart Wealth LLC increased its Bio-Rad Laboratories Class A (BIO) stake by 129% in Q2 2026, buying an estimated $2.55K and bringing the position to 16 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Bogart Wealth LLC first reported a position in BIO in Q1 2022 and has held it in 8 quarters since. The position peaked at $7K in Q2 2022. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Bogart Wealth LLC held 16 shares of Bio-Rad Laboratories Class A worth $4.7K as of Q2 2026.
Bogart Wealth LLC bought 9 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $2.55K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1219 holding.
Bogart Wealth LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 8 quarters since.
Bogart Wealth LLC's Bio-Rad Laboratories Class A position peaked at $7K in Q2 2022.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.